黄 慧,杨青岩

代谢综合征（Metabolic Syndrome，MetS）和骨质疏松症（Osteoporosis，OP）是全球范围内日益严峻的公共卫生挑战。MetS是一组以中心性肥胖、胰岛素抵抗、高血压和血脂异常为特征的代谢紊乱综合征，其各组分可能通过不同机制影响骨代谢；而骨质疏松症则以骨量减少、骨微结构破坏及骨折风险增加为主要特征。近年来，MetS和OP的患病率均呈显著上升趋势，但两者之间的关联仍存在争议，因此亟需更深入的探讨与研究。本研究旨在系统分析老年代谢综合征患者的骨密度（Bone Mineral Density，BMD）影响因素。随着全球老龄化进程加速，MetS已成为老年人群健康管理的关键问题，而骨质疏松症作为老年常见病，正逐渐被视为MetS的重要并发症。本研究通过深入探讨MetS患者的BMD变化机制，旨在为临床干预和个体化治疗策略提供循证依据，从而改善老年患者的骨骼健康及整体预后。

代谢综合征；骨密度；影响因素；老年人

[1] Sugimoto,T.;Sato,M.;Dehle,F.C.;Brnabic,A.J.;Weston,A.;Burge,R.Lifestyle-relatedmetabolic isorders,osteoporosis,and fracture risk in Asia:A systematic review.Value Health Reg.Issues 2016,9,49–56. [2] Fink HA,Ewing SK,Ensrud KE,Barrett-Connor E,Taylor BC,Cauley JA,et al.Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men.J Clin Endocrinol Metab 2006;91:3908–15. [3] Ding C,Parameswaran V,Udayan R,Burgess J,Jones G.Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults:a longitudinal study.J Clin Endocrinol Metab 2008;93:1952–8. [4] Almeida M,Han L,Martin-Millan M,Plotkin LI,Stewart SA,Roberson PK,et al.Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids.J Biol Chem 2007;282:27285–97. [5] World Health Organization.Assessment ofOsteoporosis at the Primary Health Care Level:Summary Report ofa WHO Scientific Group;World Health Organization:Geneva,Switzerland,2007. [6] Grundy SM,Cleeman JI,Daniels SR et al(2005)Diagnosis and management of the metabolic syndrome.An American Heart Association/National Heart,Lung,and Blood Institute Scientific Statement.Executive summary.Cardiol Rev 13:322–327. [7] Lee L,Sanders RA(2012)Metabolic syndrome.Pediatr Rev 33:459–468. [8] Lakka H-M,Laaksonen DE,Lakka TA,Niskanen LK,Kumpusalo E,Tuomilehto J,Salonen JT(2002)The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.JAMA 288:2709–2716. [9] Mazloomzadeh S,KaramiZarandi F,Shoghli A,Dinmohammadi H(2019)Metabolic syndrome,its components and mortality:a population-based study.Med J Islam Repub Iran 33:11. [10] Kaur,J.A comprehensive review on metabolic syndrome.Cardiol.Res.Pract.2014,2014,21. [11] Hippisley-Cox,J.;Coupland,C.Predicting risk of osteoporotic fracture in men and women in England and Wales:Prospective derivation and validation of QFractureScores.BMJ 2009,339,b4229. [12] Wong SK,Chin KY,Suhaimi FH,Ahmad F,Jamil NA,Ima-Nirwana S(2018)Osteoporosis is associated with metabolic syndrome induced by high-carbohydrate high-fat diet in a rat model.Biomed Pharmacother 98:191–200. [13] da Silva VN,Fiorelli LNM,da Silva CC,Kurokawa CS,Gold-berg TBL(2017)Do metabolic syndrome and its components have an impact on bone mineral density in adolescents?Nutr Metab(Lond)14:1–1. [14] Chin KY,Wong SK,Ekeuku SO,Pang KL(2020)Relationship between metabolic syndrome and bone health-an evaluation of epidemiological studies and mechanisms involved.Diabetes Metab Syndr Obes 13:3667–3690. [15] James DE,Stöckli J,Birnbaum MJ(2021)The aetiology and molecular landscape of insulin resistance.Nat Rev Mol Cell Biol 22(11):751–771. [16] Rønne MS,Heidemann M,Lylloff L et al(2019)Bone mass development is sensitive to insulin resistance in adolescent boys.Bone 122:1–7. [17] Mohan,S.;Baylink,D.J.Impaired skeletal growth in mice with haploinsufficiency of IGF-I:Genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences.J.Endocrinol.2005,185,415–420. [18] Zhang,M.;Xuan,S.;Bouxsein,M.L.;von Stechow,D.;Akeno,N.;Faugere,M.C.;Malluche,H.;Zhao,G.;Rosen,C.J.;Efstratiadis,A.;et al.O-steoblast-specific knockout of the insulin-like growth factor(IGF)receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.J.Biol.Chem.2002,277,44005–44012. [19] Chin,K.Y.;Ima-Nirwana,S.;Mohamed,I.N.;Johari,M.H.;Ahmad,F.;Ramli,E.S.M.;Wan Ngah,W.Z.Insulin-like growth factor-1 is a mediator of age-related decline of bone health status in men.Aging Male 2014,17,102–106. [20] Jackuliak,P.;Payer,J.Osteoporosis,fractures,and diabetes.Int.J.Endocrinol.Metab.2014,2014,10. [21] World Health Organization:Obesity:Preventing and managing the global epidemic,no.894.2000,Geneva:WHO. [22] Palermo,A.;Tuccinardi,D.;Defeudis,G.;Watanabe,M.;D’Onofrio,L.;Lauria Pantano,A.;Napoli,N.;Pozzilli,P.;Manfrini,S.BMI and BMD: The Potential Interplay between Obesity and Bone Fragility.Int.J.Environ.Res.Public Health 2016,13,544. [23] Kang,D.H.;Guo,L.F.;Guo,T.;Wang,Y.;Liu,T.;Feng,X.Y.;Che,X.Q.Association of body composition with bone mineral density in northern Chinese men by different criteria for obesity.J.Endocrinol.Investig.2015,38,323–331. [24] Iwaniec,U.T.;Turner,R.T.Influence of body weight on bone mass,architecture and turnover.J.Endocrinol.2016,230,R115–R130. [25] Compston JE,Watts NB,Chapurlat R,et al.Obesity is not protective against fracture in postmenopausal women:GLOW.Am J Med 2011;124:1043–1050. [26] Greco EA,Fornari R,Rossi F,et al.Is obesity protective for osteoporosis?Evaluation of bone mineral density in individuals with high body mass index.Int J Clin Pract 2010;64:817–820. [27] Metz JA,Morris CD,Roberts LA,McClung MR,McCarron DA(1999)Blood pressure and calcium intake are related to bone density in adult males.Br J Nutr 81:383–388. [28] Cappucio FP,Meilahn E,Zmuda JM,Cauley JA(1999)High blood pressure and bone-mineral loss in elderly white women:a prospective study.Study of Osteoporotic Fractures Research Group.Lancet 354:971–975. [29] Vestergaard P,Rejnmark L,Mosekilde L(2009)Hypertension is a risk factor for fractures.Calcif Tissue Int 84:103–111. [30] Parvanova A,Reseghetti E,Abbate M,Ruggenenti P(2023)Mechanisms and treatment of obesity-related hypertension-Part 1:Mechanisms.Clin Kidney J 17:sfad282. [31] Anagnostis,P.;Florentin,M.;Livadas,S.;Lambrinoudaki,I.;Goulis,D.G.Bone Health in Patients with Dyslipidemias:An Underestimated Aspect.Int.J.Mol.Sci.2022,23,1639. [32] Lidfeldt J,Holmdahl L,Samsioe G et al(2002)The influence of hormonal status and features of the metabolic syndrome on bone density:a population-based study of Swedish women aged 50 to 59 years.The women’s health in the Lund area study.Metabolism 51:267–270. [33] Kim J,Ha J,Jeong C et al(2022)Bone mineral density and lipid profiles in older adults:a nationwide cross-sectional study.Osteoporos Int 34:119–128. [34] Bae SJ,Son HY,Pyun DK,Nah SS,Koh JM,Kim GS.Higher circulating hs-CRP levels are associated with lower bone mineral density in healthy premenopausal and postmenopausal women:evidence for link between systemic inflammation and osteoporosis.Korean J Bone Metab 2004;11:147–157.

点击下载PDF